|
End-of-day quote
LUXEMBOURG S.E.
2026-09-21
|
5-day change | 1st Jan Change | ||
| 14.50 USD | +1.40% |
|
+1.40% | -13.69% |
| 09-03 | India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar | RE |
| 08-25 | Cipla's Pithampur, India Unit Gets 7 Observations From US FDA | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CIPLA LIMITED | Generic Pharmaceuticals | +1.40% | +1.40% | -13.69% | -18.99% | +11.54% | 11.69B |
-
|
-
|
-
|
- Stock Market
- Stocks
- CIPLA Stock
- CIPLA Stock
- Charts Cipla Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
